BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stasi C, Silvestri C, Voller F. Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination. SN Compr Clin Med. 2020;1-8. [PMID: 33103061 DOI: 10.1007/s42399-020-00588-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Carty PG, Teljeur C, De Gascun CF, Gillespie P, Harrington P, McCormick A, O'Neill M, Smith SM, Ryan M. Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program. Value Health 2022:S1098-3015(22)01998-2. [PMID: 35778325 DOI: 10.1016/j.jval.2022.05.010] [Reference Citation Analysis]
2 Santana GM, Silva AKS, Foguel MV, Dutra RF. An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole–graphene nanocomposite. J Mater Sci. [DOI: 10.1007/s10853-022-06992-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wyatt B, Perumalswami PV, Mageras A, Miller M, Harty A, Ma N, Bowman CA, Collado F, Jeon J, Paulino L, Dinani A, Dieterich D, Li L, Vandromme M, Branch AD. A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure. Hepatology 2021;74:2974-87. [PMID: 34333777 DOI: 10.1002/hep.32086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma A, Mishra RK, Goud KY, Mohamed MA, Kummari S, Tiwari S, Li Z, Narayan R, Stanciu LA, Marty JL. Optical Biosensors for Diagnostics of Infectious Viral Disease: A Recent Update. Diagnostics (Basel) 2021;11:2083. [PMID: 34829430 DOI: 10.3390/diagnostics11112083] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 McCormick CA, Domegan L, Carty PG, Drew R, McAuliffe FM, O'Donohoe O, White N, Garvey P, O'Grady M, De Gascun CF, McCormick PA. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study. BJOG 2022;129:322-7. [PMID: 34706147 DOI: 10.1111/1471-0528.16984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mpekoulis G, Tsopela V, Panos G, Siozos V, Kalliampakou KI, Frakolaki E, Sideris CD, Vassiliou AG, Sideris DC, Vassilacopoulou D, Vassilaki N. Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway. Viruses 2021;13:2139. [PMID: 34834946 DOI: 10.3390/v13112139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Shenge JA, Osiowy C. Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries. Front Virol 2021;1:742722. [DOI: 10.3389/fviro.2021.742722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kim KA, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Ki M, Choi HY, Paik D, Jeong SH. Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID. Epidemiol Health 2021;43:e2021077. [PMID: 34645207 DOI: 10.4178/epih.e2021077] [Reference Citation Analysis]
9 Carvalho SCR, Vasconcelos LRS, Fonseca LD, Carmo RF, Tomitão MT, Aroucha DCBL, Pereira LMMB, Stefano JT, Ribeiro-Júnior U, Oliveira CP, Carrilho FJ. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). Clinics (Sao Paulo) 2021;76:e2881. [PMID: 34644732 DOI: 10.6061/clinics/2021/e2881] [Reference Citation Analysis]
10 Permanasari AA, Aoki-Utsubo C, Wahyuni TS, Tumewu L, Adianti M, Widyawaruyanti A, Hotta H, Hafid AF. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs. BMC Complement Med Ther 2021;21:260. [PMID: 34641875 DOI: 10.1186/s12906-021-03408-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Facente SN, Patel S, Hecht J, Wilson E, McFarland W, Page K, Vickerman P, Fraser H, Burk K, Morris MD. Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs. Clin Infect Dis 2021;73:e1290-5. [PMID: 33768236 DOI: 10.1093/cid/ciab261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Qu LX, Shi Y, Chen KY, Lu YH, Ren H. The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial study. BMC Infect Dis 2021;21:974. [PMID: 34536999 DOI: 10.1186/s12879-021-06577-8] [Reference Citation Analysis]
13 Grzegorzewska AE, Mostowska A, Warchoł W, Jagodziński PP. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study. BMC Infect Dis 2021;21:875. [PMID: 34445971 DOI: 10.1186/s12879-021-06597-4] [Reference Citation Analysis]
14 Higuera-de la Tijera F, Servín-Caamaño A, Servín-Abad L. Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination. World J Gastroenterol 2021; 27(26): 4004-4017 [PMID: 34326610 DOI: 10.3748/wjg.v27.i26.4004] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Doica IP, Florescu DN, Oancea CN, Turcu-Stiolica A, Subtirelu MS, Dumitra G, Rogoveanu I, Gheonea DI, Ungureanu BS. Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study. Int J Environ Res Public Health 2021;18:3694. [PMID: 33916226 DOI: 10.3390/ijerph18073694] [Cited by in F6Publishing: 10] [Reference Citation Analysis]